The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Thursday, January 18, 2018
Biohaven announced the U.S. Food and Drug Administration (FDA) has notified the company that it may proceed with its clinical investigation of BHV-...
read more
Agenus announced the launch of its combination trial with its proprietary anti-CTLA4 (AGEN1884) and anti-PD1 (AGEN2034) antibodies.
read more
BERG announced the U.S. Food and Drug Administration (FDA) has granted orphan-drug designation to the company's leading product candidate BPM31510, ...
read more
Tuesday, January 23, 2018
ProMIS has announce its lead product candidate for Alzheimer's disease, PMN310, showed significantly greater binding to the neurotoxic oligomer-...
read more
Tuesday, January 23, 2018
Swedish Orphan Biovitrum AB announced the FDA has accepted the IND application for the drug candidate SOBI003.
read more
Wednesday, January 24, 2018
BioAtla announced the U.S. Food and Drug Administration (FDA) has cleared BioAtla's Investigational New Drug application (IND) for BA3011.
read more
GlaxoSmithKline Pharmaceuticals
GlaxoSmithKline and Innoviva announced the EMA’s CHMP has issued a positive opinion recommending a label update for the use of once-daily Relvar ...
read more
The FDA approved Lutathera for the treatment of a type of cancer that affects the pancreas or gastrointestinal tract called GEP-NET.
read more
Takeda announced that the FDA has granted Fast Track designation to TAK-426, Takeda’s purified, inactivated, alum-adjuvanted, whole Zika virus vaccine...
read more
Theravance Biopharma and Mylan announced the FDA has accepted for review the companies' recently submitted NDA for revefenacin (TD-4208).
read more
Tuesday, January 30, 2018
Dauntless Pharmaceuticals has granted orphan drug designation to DP1038.
read more
Thursday, February 01, 2018
Imago BioSciences announced the FDA has accepted their IND application providing clearance to proceed with the clinical development of IMG-7289 in the...
read more
Monday, February 05, 2018
Trethera announced the FDA has cleared its IND application for TRE-515, a novel, first-in-class inhibitor of deoxycytidine kinase for the treatment of...
read more
Tuesday, February 06, 2018
Treatment with the combination of encorafenib and binimetinib reduced the risk of death compared to treatment with vemurafenib.
read more
Wednesday, February 07, 2018
Bristol-Myers Squibb announced the ongoing Phase 3 study met its co-primary endpoint of PFS with the Opdivo plus Yervoy combination in first-line ...
read more